Department of General Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China.
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2442-2451. doi: 10.26355/eurrev_202003_20511.
This study was aimed to investigate the expression characteristics of ETS variant 4 (ETV4) in gastric cancer (GCa), and to further explore whether it promotes the development of GCa by regulating KDM5D.
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) was performed to examine the expression of ETV4 in 35 pairs of tumor tissue and paracancerous tissue specimens collected from GCa patients, and the interplay between ETV4 expression and clinical indexes, as well as the prognosis of GCa patients, were analyzed. Meanwhile, the expression of ETV4 in GCa cell lines was verified using qRT-PCR assay. Furthermore, ETV4 knockdown model was constructed using lentivirus in GCa cell lines including AGS and BGC-823, and then, the transwell invasion and cell wound healing assays were applied to analyze the effect of ETV4 on the biological function of GCa cells. In addition, an in-depth study of the relationship between ETV4 and KDM5D was conducted.
The results of qRT-PCR showed that the expression level of ETV4 in GCa tissue samples was remarkably higher than that in adjacent tissues, and the difference was statistically significant. Compared with patients with low expression of ETV4, the patients with high ETV4 expression had a higher occurrence rate of lymph node or distant metastasis and a lower overall survival rate. Similarly, the metastasis ability of GCa cells in the ETV4 expression knockdown group (sh-ETV4) was remarkably decreased when compared with the sh-NC group. In addition, qRT-PCR results indicated that the protein expression of KDM5D was significantly increased after the knockdown of ETV4. Therefore, it was demonstrated that ETV4 might be able to regulate the malignant progression of GCa via modulating KDM5D expression. Finally, the results of the cell reverse experiment confirmed that the silence of ETV4 could reverse the malignant progression of GCa induced by the downregulation of KDM5D.
ETV4 expression was found remarkably elevated in GCa tissues and was significantly associated with the occurrence of lymph node or distant metastasis and poor prognosis. In addition, ETV4 might promote GCa cell metastasis by modulating KDM5D.
本研究旨在探讨 ETS 变异体 4(ETV4)在胃癌(GCa)中的表达特征,并进一步探讨其是否通过调节 KDM5D 促进 GCa 的发展。
采用定量实时聚合酶链反应(qRT-PCR)检测 35 对胃癌患者肿瘤组织和癌旁组织标本中 ETV4 的表达情况,分析 ETV4 表达与临床指标及 GCa 患者预后的关系。同时,采用 qRT-PCR 检测 GCa 细胞系中 ETV4 的表达。构建 GCa 细胞系 AGS 和 BGC-823 的慢病毒 ETV4 敲低模型,然后应用 Transwell 侵袭和细胞划痕愈合实验分析 ETV4 对 GCa 细胞生物学功能的影响。此外,还对 ETV4 与 KDM5D 之间的关系进行了深入研究。
qRT-PCR 结果显示,GCa 组织样本中 ETV4 的表达水平明显高于相邻组织,差异具有统计学意义。与 ETV4 低表达患者相比,高 ETV4 表达患者的淋巴结或远处转移发生率更高,总生存率更低。同样,与 sh-NC 组相比,ETV4 表达敲低组(sh-ETV4)的 GCa 细胞转移能力显著降低。此外,qRT-PCR 结果表明,ETV4 敲低后 KDM5D 的蛋白表达显著增加。因此,表明 ETV4 可能通过调节 KDM5D 的表达来调控 GCa 的恶性进展。最后,细胞反向实验结果证实,沉默 ETV4 可逆转 KDM5D 下调诱导的 GCa 恶性进展。
ETV4 在 GCa 组织中表达明显升高,与淋巴结或远处转移和不良预后显著相关。此外,ETV4 可能通过调节 KDM5D 促进 GCa 细胞转移。